c14.than
nism between the ureter and the bladder (the
vesicoureteric junction; Figure 14.20), Vesi-
coureteric reflux leading to reflux nephropathy usually starts in infancy, and may stabilize or
progress slowly to CRF in adulthood.
In bladder outflow obstruction, e.g. prostatic hypertrophy, urinary retention may be accom-
modated by bladder distension, with little serious rise in intrarenal pressure.
Aetiology
The commonest causes of obstruction are listed
in Table 14.22. In the West, the most frequent
causes are gynaecological problems in women,
prostatic hypertrophy in men, and stones in
both.
Renal calculi (urolithiasis)
The lifetime prevalence of renal stones is about
10% in males and 5% in females, although not
all cases are symptomatic. The causes are poorly
understood. Calcium oxalate stones, the most
common type, may result from hypercalciuria
(high urinary calcium) or excessive gastro-
intestinal absorption of oxalate (hyperoxaluria).
Stone formation is encouraged by an alkaline
urine, e.g. from renal tubular acidosis, and
hyperuricosuria, e.g. in hyperuricaemia or gout
(Chapter 12). Conversely, hyperuricaemia
together with an acid urine predisposes to urate
stones. In urinary infections caused by urease-
producing organisms, especially Proteus spp., the
urinary alkalinity and ammonium content cause
co-precipitation of mixed phosphate stones
(calcium, magnesium and ammonium). In
cystinuria, an inherited metabolic disorder, the
reduced tubular reabsorption of cystine results in
high urinary levels and cystine stone formation.
Clinical features and investigation
Symptoms depend on whether the lesion is
above or below the bladder outlet. In the latter
case, dysuria, hesitancy, frequency, terminal
dribbling or bladder distension and discomfort
occur. Above-bladder obstruction usually causes
renal colic (sudden severe and debilitating
unilateral loin pain due to ureteric spasm) often
associated with haematuria and complete
ureteric obstruction. Colic is also caused by the movement of stones in the ureter.
The urine flow disturbance will also depend on
the degree and site of obstruction and whether it
is bilateral. Paradoxically, polyuria may occur,
owing to tubular damage. Chronic reflux
nephropathy, caused by bladder contents being
refluxed into the renal pelvis, may result in
hypertension and recurrent renal infection
(pyelonephritis).
Investigation ranges from simple examination and analysis of the urine to sophisticated imaging and biopsy.
Management
Whereas surgery used to be common in treating
obstruction, conservative management is increas-
ingly used, owing to the growing appreciation
that renal function may be preserved or restored,
and to the development of techniques of percuta-
neous intrarenal manipulation. Surgical repair
may be essential in some cases, e.g. a congenital
defect, but nephrectomy is now quite rare.
Small stones (especially cystine) may be
passed in the urine if output is encouraged by
ample fluid intake (more than 3L daily),
especially overnight. Antispasmodics such as
propantheline (contra-indicated in bladder
outflow obstruction) or catheterization may also
assist the passage of stones. Penicillamine will
help to dissolve cystine stones. Reducing
urinary urate levels with allopurinol may help.
Alkalinization of the urine, e.g. with potassium
citrate mixture, will also reduce hypercalciuria
and in turn the formation of both urate and
cystine stones. Urinary acidification, e.g. with
ammonium chloride, will minimize phosphate
stone production.
For oxalate stones, sodium restriction and thiazides are used both to reduce urinary calcium (thiazides promote tubular reabsorption of calcium) and to increase urine flow. It is impor-
tant not to reduce dietary calcium in an attempt to treat hypercalciuria, because, paradoxically, this tends to increase future stone formation and also cause loss of calcium from bones.
Nephrostomy may permit extraction of larger
pelvic stones and drainage in hydronephrosis.
Stones may be ultrasonically disrupted by extra-
corporeal shock-wave lithotripsy (ESWL) and the
fragments passed out in the urine. Fibre-optic
ureteroscopy, which requires general anaesthetic,
may be required. Open surgery is rarely necessary.
In reflux nephropathy prompt treatment of
infections and adequate control of hypertension are likely to prevent progression. Surgery is rarely indicated, except for reconstruction of a congen-
itally abnormal vesicoureteric junction.
Renal colic is treated with either pethidine or,
increasingly, an NSAID (diclofenac), which
reduces ureteric spasm in addition to its anal-
gesic effect. IV fluids are used to promote urine
flow, especially as the patient is likely to be
extremely nauseous.
In all methods employing treatments to encourage urine flow, it is of course important to ensure initially that there is not complete
obstruction.
Infection
As with obstruction, there is a significant differ-
ence between infections of the lower and upper
renal systems. Lower urinary-tract infection (e.g.
urethritis, cystitis) causes discomfort, inconve-
nience and not a little pain, but is essentially
benign if restricted to a single attack at that site.
Conversely, infection of the kidney (upper
urinary-tract infection or pyelonephritis) is
always serious and has systemic complications. It
may even lead to CRF: indeed, chronic
pyelonephritis accounts for some 10% of all
ESRD.
However, urinary-tract infection and
pyelonephritis are not completely distinct. Most
kidney infections are presumed to have ascended
from asymptomatic, untreated or inadequately
treated urinary-tract infection, and this retro-
grade infection is encouraged by the urinary
stasis, which can result from obstruction.
Repeated or serious urinary-tract infection can
itself lead to obstruction by causing ureteric
fibrosis and stricture (narrowing). The patholog-
ical spectrum, from asymptomatic bacteriuria to
what is still termed chronic pyelonephritis, is
illustrated in Figure 14.21.
Because pyelonephritis causes inflammatory
damage there is also some pathological similarity
to such conditions as nephrotoxicity, analgesic
nephropathy, reflux nephropathy and the renal
manifestations of connective tissue disorders,
e.g. SLE. The generic term interstitial nephritis is
often preferred.
Urinary-tract infection
Because of the close pathogenetic links between
urinary-tract infection, reflux nephropathy,
obstruction and pyelonephritis, some of the
general features of urinary-tract infection are
discussed here so as to present a complete
picture of renal system infections. Full details of
urinary-tract infections, especially their investi-
gation and management, are given in Chapter 8.
Aetiology and pathology
Urine is normally sterile. The faecal commensal
Escherichia coli is responsible for acute infection in
75% of those cases where a urinary organism is
identified. Less common pathogens include
staphylococci, faecal streptococci, Proteus and
Klebsiella. Non-specific urethritis (i.e. non-
gonococcal) is usually caused by Chlamydia spp.
Women. Even with the strictest hygiene,
urinary-tract contamination with skin commen- sals or faecal organisms is difficult to avoid in
women. This is due to the anatomical proximity
of the urethral and anal openings, and the rela-
tively short urethra. Simple urinary-tract infec-
tion is far more common among women than
men.
The route of infection may be anus-
vagina-vulva-urethra. Vaginal secretions, urine
and the urinary tract all normally have protec-
tive antimicrobial properties, e.g. mucosal IgA,
locally acidic pH, frequent flow. Thus, recurrent
infection suggests a breakdown in these defence
mechanisms, e.g. obstruction, or a protected
focus of infection, e.g. infected stones. Persisting
vaginal organisms may be introduced into the
urethra mechanically, especially during inter-
course - hence the rather quaint but now
distinctly anachronistic term ‘honeymoon
cystitis’. Urinary-tract infection is more common
among postmenopausal women owing possibly
to a loss of protection afforded by oestrogens.
Although bacteriuria is found in about 5% of
adult women, few of these suffer symptoms.
Such asymptomatic or covert bacteriuria gener-
ally does not require treatment except during
pregnancy, where there is a 30% chance of
progression to acute pyelonephritis due to intra-
abdominal ureteric compression. On the other
hand, no organism can be found in up to 50% of
women who do have symptoms of cystitis; this is
known as abacterial cystitis (or ‘urethral
syndrome’).
Men. Infection in males is much rarer and
always requires investigation. Sexually trans-
mitted non-specific urethritis is the most common cause in young men and chronic bac-
terial prostatitis in older men.
Both sexes. In the elderly of either sex the
prevalence of urinary-tract infection may rise to 30% and this is a particular problem in institu-
tions. Catheterization alone carries a risk of infec-
tion variously estimated at between 2% and 20%. In diabetics, reduced host defence and glycosuria predispose to urinary bacterial growth.
Clinical features and course
The hallmark of acute urethritis/cystitis is an
intense burning sensation on micturition, to
which the simple term dysuria fails to do justice.
The condition may be exacerbated by a more
acid urine resulting from local bacterial metabo-
lism. Urinary frequency is common and there
may be suprapubic pain or discomfort. Pyuria,
purulent discharge or even haematuria may also
occur but, although alarming and requiring
investigation, are not necessarily sinister. There
are no systemic signs. The elderly commonly
present with acute confusion, fever, malaise or
anorexia but few specific urinary symptoms,
making it easy to miss during examination. It is
also difficult to spot in young children if not
suspected.
Urinary-tract infection is usually self-limiting within a few days, especially if fluid intake is promptly increased substantially. It may have no complications in the absence of any other renal abnormality. However, recurrence is common owing either to infection with a different organism, or to relapse or re-infection with the same organism. The latter situation suggests the presence of a complicating factor that is preventing complete eradication.
Investigation
Two things must be determined: (i) which
organism is responsible; and (ii) are there any
underlying causes or correctable complications?
The collection of urine samples and the indica-
tions for further investigation are discussed in
Chapter 8.
Management
In the management of urinary-tract infection
the aims are to:
• reduce the risk of renal damage. • provide symptomatic relief.
• render the urine sterile.
• provide prophylactic therapy.
The first of these is achieved by prompt atten-
tion and full investigation when appropriate.
General measures include increasing the fluid
intake substantially to promote urine flow, and
providing advice on hygiene. For women, advice
includes front-to-back wiping after defaecation
(although the role of this has been disputed),
and micturition before and after coitus. Frequent
recurrence or relapse in the absence of obstruc-
tive or other correctable complications may
require prophylactic therapy. For details of treat-
ment, see Chapter 8.
Acute pyelonephritis
Like lower urinary-tract infection, most cases of acute pyelonephritis (APN) occur in women. E. coli is the usual culprit, but Proteus, Staphylo-
coccus and Pseudomonas are found more commonly than in simple urinary-tract infec-
tion. Tubular inflammation causes polyuria and a dilute urine but severe cases may progress to acute oliguric renal failure.
Clinical features
An acute onset of severe loin pain is accompa-
nied by systemic features such as fever, nausea
and vomiting. There may also be lower urinary-
tract infection symptoms of cystitis and
urethritis (Figure 14.20). Rarely, if both kidneys
are affected, tubular oedema and inflammatory
exudate may cause intrarenal obstruction with
acute post-renal failure.
Management
Prompt appropriate oral antimicrobial therapy and an increased fluid intake are always indi-
cated. The same agents are used as in urinary-
tract infection. However, close attention to microbiological results is vital because of the
greater likelihood of unusual or resistant organ-
isms and the importance of characterizing recur-
rence as either relapse, i.e. the same organism, or re-infection possibly with another.
Most patients have a single attack of APN
and recover completely, but recurrent attacks
or persistent asymptomatic bacteriuria require
further investigation. If the recurrence is a
relapse with the same organism, either the
antimicrobial therapy was inadequate or
there may be obstructive/reflux abnormalities.
Frequent re-infection with different organisms
or strains suggests that the host defences are
defective, and that prophylactic antimicrobial
therapy should be considered. This can be
continuous low-dose therapy, or intermittent
5-day full-dose courses at the onset of symp-
toms, which the patient can be instructed to
initiate.
Reflux nephropathy (chronic pyelonephritis)
Definition
The term chronic pyelonephritis has traditionally
been used to describe a condition diagnosed radi-
ologically where one or both kidneys appear irreg-
ular, shrunken and scarred. However, because
evidence is accumulating of a strong association
with reflux or infection, the term reflux
nephropathy is now preferred. Although most
cases do not progress to renal failure, it can be
extremely difficult to treat, and renal scarring is
present in up to 20% of patients starting dialysis.
Pathogenesis
The relative contributions of chronic infection
and sterile reflux (causing simple pressure
damage) are still uncertain. Many patients have
neither bacteriuria nor a history of urinary-tract
infection, and although urinary-tract infection
and APN are far more common in women,
reflux nephropathy shows equal sex distribu-
tion. One form may result from vesicoureteric
reflux starting in the very young, and this has a
poorer prognosis because it may be silent or
undiagnosed for long periods. In adults, recur-
rent urinary-tract infection or APN may be
responsible.
Bacterial reflux nephropathy commonly
involves more virulent Gram-negative organ-
isms, including Pseudomonas, and persistent
infection with relapses is common. In contrast to
the urinary tract the renal pelvis seems to have
no natural antibacterial defences (presumably
evolution never anticipated organisms there).
There may even be factors that encourage the
microbial persistence, so complete eradication is
difficult.
Clinical features and investigation
The condition may be asymptomatic or may
present as proteinuria, hypertension or recurrent
urinary-tract infection. Rarely, the first indica-
tion may be symptoms of incipient renal failure
Important renal diseases 935
such as polyuria or nocturia, because the renal
damage is primarily tubular. Early reflux damage
may initiate the hypertension-renal failure
vicious cycle, and sometimes a history of related
childhood illnesses such as enuresis or cystitis
may be traced. Diagnosis and investigation
involve urography, urine microbiology and renal
function tests.
Management
In the absence of renal impairment, all that may
be required is regular monitoring of blood pres-
sure, urine microbiology and renal function.
Infective episodes must be treated promptly as
for APN, and appropriate antimicrobial prophy-
laxis may be indicated if bacteriuria cannot be
eliminated. In children, surgery to correct reflux
may be necessary.
Course and prognosis
Most patients have stable disease, especially if their BP and bacteriuria are managed success-
fully. Recurrent infective exacerbations carry a poorer prognosis, but only about 1% of patients progress to CRF.
Glomerular disease
Glomerular disease invariably affects both kidneys. Glomeruli seem especially sensitive to inflammatory immune damage, and most forms of glomerular disease involve immunological mechanisms. Glomerulonephritis (GN) is the single most important cause of CRF.
Classification
For such a small and apparently simple structure
the glomerulus presents inordinate pathological
complexity. Descriptions of glomerular disease
have a long history in medicine, and under-
standing of the condition is confounded by the
numerous methods of classification. Moreover,
increasingly sophisticated microscopy and
immunological techniques continue to identify
new criteria and subgroups. Thus, in addition to simple clinical and aetiological classes there are histopathological and immunopathological groupings (Table 14.23).
There is no consistent correlation between
these different methods of classification and
much overlap. No single classification provides
an unequivocal guide to management, and
usually each aspect needs to be specified
Bạn đang đọc truyện trên: Truyen2U.Net